In today’s article we take a look at the companies that issue headlines at the beginning of the trading week.
Tesla – Tesla plans to reveal its newest addition, the Model Y SUV on March 14. The CEO of the company, Elon Musk, has announced that the car will cost about 10% more than Model 3 and its range will be just slightly shorter. Tesla paid convertible bonds worth $920 million in cash late Friday. The settlement was monetary because Friday’s closing of $294.79 was lower than the conversion rate of $359.87.
Amazon – The price of Amazon grew to $1,965 after it was previously standing at around $1,800 per share. The company said that gross profit growth is now the best measure from which to assess the company, noting that the transformation of the business mix means that gross profit will probably gain four percentage points faster than revenues over the next three years.
Eli Lilly – The pharmaceutical company has issued a new generic version of its Humalog insulin. The good news is that the new version will cost 50% less than the first one.
CVS Health – Modifications in how the government pays kidney disease treatments might be beneficial for CVS. Reuters reported that the debated changes would lead to lower cost treatments, an area in which the company contributes significantly, and that CVS the changes could pose a danger to competitors such as DaVita and Fresenius Medical Care.
Vale – Chief Executive Officer Fabio Schvartsman resigned this weekend, together with a group of senior executives of the Brazilian mining company. This comes amid the mining dam disaster that happened in January this year, which killed hundreds of people.
Children’s Place – The famous children’s clothing brand gained an adjusted $1.10 per share in the fourth quarter, well below the estimates of $2.10. The company’s revenue also failed to meet expectations, and the earnings forecasts for the full year are also well below economists’ expectations. The company said that the numbers were negatively affected by the bankruptcy and liquidation of rival company Gymboree. Children’s Place bought the rights of the Gymboree brand in court action.
Biogen – The company has announced the purchase of Nightstar Therapeutics, a UK gene therapy company, for the price of $25.50 per share. The number is 68 percent above Friday’s closing at $15.16 per share.
Foot Locker – The trade signal for the company was changed to “buy” from “hold” by Pivotal Research, after the company’s positive fourth quarter earnings. The share price also rose to $73 from a previous $64.
Kraft-Heinz – The previous fears of dividend cuts and lack of revenue were now priced in the stock after the recent decline.
Bed Bath & Beyond – Barclays Bank downgraded its retailer’s stock to “underweight” from a previous “equal weight”, saying it was increasingly disappointed with the way the company tried to implement a large-scale restructuring.
Dillard’s – JPMorgan Chase downgraded retail stocks to “underweight” from “neutral”, after a 25% growth since the beginning of the year. The rating downgrade also comes amid increasing inventory levels, as reports suggest that in the past, high inventory levels caused negative effects.